Expert partnership to explore and establish Human Challenge studies of COVID-19 in the UK
£33.6 million government investment will back the studies in partnership with Imperial College London, hVIVO and the Royal Free London NHS Foundation Trust.
A Marm Kilpatrick
UK announces details of human challenge trials to assess the minimal infectious dose of SARS-CoV-2. Nothing about liability, insurance against any resulting disability, or participants perceptions of associated risks, though.